Schedule 13G ownership disclosure

Amphastar Pharmaceuticals Inc

Security class unavailable · CUSIP: 03209R103

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
5,514,765
Percent of class
12.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000215457-18-001288
Form type
SC 13G/A
Filer
Amphastar Pharmaceuticals, Inc.
CIK
CIK 1297184
Filed
Jan 19, 2018
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub